London & Capital Asset Management Ltd

Position in MRK — Merck & Co., Inc.

CIK 1767559 London, X0

Position in MRK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,412,600

+$54,647 QoQ

Shares Held

10,993

-2.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,834

of 3,769 holders

Holding Since

Mar 2020

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

London & Capital Asset Management Ltd holds $7,884,378 across 5 Drug Manufacturers - General names. MRK ranks #3 (17.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,513	$2,416,016
2	LLY	ELI LILLY & Co	1,987	$2,383,267
3	MRK	Merck & Co., Inc. This page	10,993	$1,412,600
4	ABBV	AbbVie Inc.	5,460	$1,373,954
5	GILD	Gilead Sciences, Inc.	2,363	$298,541

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,412,600	10,993	-2.6%	Shares	Sole	2026-08-12
2026-03-31	$1,357,953	11,289	+0.9%	Shares	Sole	2026-05-15
2025-12-31	$1,177,859	11,190	+97.4%	Shares	Sole	2026-02-17
2020-06-30	$438,383	5,669	+46.5%	Shares	Other	2020-08-14
2020-03-31	$297,680	3,869	—	Shares	Other	2020-05-15
No filing history on record for this holder in this stock.